Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study – JAMA Oncology
Adrienne Hislop2024-03-01T11:34:11-07:00Authors: David Eldred-Evans, MBBS; Paula Burak, MS; Martin J. Connor, MBBS; et al Question In men invited to undergo screening for prostate cancer with magnetic resonance imaging (MRI), ultrasonography, and prostate-specific antigen testing, what is the prevalence of positive test results, rates of biopsy, and detection of prostate cancer? Read the article in JAMA Oncology